Advertisement

Topics

"An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects" Drugs and Medication Database

19:49 EST 22nd January 2019 | BioPortfolio

Here are the most relevant "An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects" Drugs and Medications that we have found in our database.

More Information about "An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects" on BioPortfolio

We have published hundreds of An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects news stories on BioPortfolio along with dozens of An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects Clinical Trials and PubMed Articles about An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects Companies in our database. You can also find out about relevant An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects Drugs and Medications on this site too.

Showing "Open Label Phase Study Dopamine Transporter Receptor Occupancy" Drugs and Medications 1–25 of 111

Possibly Relevant

Cycloset [Santarus, Inc.]

These highlights do not include all the information needed to use CYCLOSET safely and effectively. See full prescribing information for CYCLOSET. CYCLOSET (bromocriptine mesylate) Tablets, for oral useInitial U.S. Approval: 1978

Aprepitant [Glenmark Pharmaceuticals Inc., USA]

These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral use Initial U.S. Approval: 2003

Aprepitant [Sandoz Inc]

These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral useInitial U.S. Approval: 2003

Varubi [Tesaro, Inc.]

These highlights do not include all the information needed to use VARUBI safely and effectively. See full prescribing information for VARUBI. VARUBI (rolapitant) tablets, for oral useVARUBI (rolapitant) injectable emulsion, for intravenous useInitial U.S.

Emend [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use EMEND safely and effectively. See full prescribing information for EMEND. EMEND (aprepitant) CapsulesInitial U.S. Approval: 2003

Emend [Merck Sharp & Dohme Corp.]

These highlights do not include all the information needed to use EMEND CAPSULES and EMEND FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EMEND CAPSULES and EMEND FOR ORAL SUSPENSION. EMEND (aprepitant) capsules, for oral

Emend [Rebel Distributors Corp]

These highlights do not include all the information needed to use EMEND safely and effectively. See full prescribing information for EMEND. EMEND (aprepitant) CapsulesInitial U.S. Approval: 2003

Dexmethylphenidate hydrochloride [Sun Pharmaceutical Industries, Inc.]

Dexmethylphenidate Hydrochloride Tablets CII Rx Only

Focalin [Novartis Pharmaceuticals Corporation]

Focalin Rx only Prescribing Information

Dexmethylphenidate hydrochloride [Tris Pharma Inc]

Dexmethylphenidate Hydrochloride Tablets CII Rx only

Dexmethylphenidate hydrochloride [Sandoz Inc]

Dexmethylphenidate Hydrochloride Tablets CII Rx only

Dexmethylphenidate hydrochloride [Rhodes Pharmaceuticals L.P.]

Dexmethylphenidate Hydrochloride Tablets

Dexmethylphenidate hydrochloride [Lupin Pharmaceuticals,Inc.]

Dexmethylphenidate Hydrochloride Tablets CII Rx only

Dexmethylphenidate hydrochloride [Lannett Company, Inc.]

Dexmethylphenidate Hydrochloride Tablets CIIRx only

Modafinil [STAT Rx USA LLC]

Modafinil Tablets C-IV 200 mg

Modafinil [Dispensing Solutions, Inc.]

Modafinil Tablets

Modafinil [AvKARE, Inc.]

Modafinil Tablets, USP

Modafinil [Aphena Pharma Solutions - Tennessee, LLC]

Modafinil Tablets

Modafinil [Hikma Pharmaceutical]

Modafinil Tablets USP

Provigil [Lake Erie Medical Surgical & Supply DBA Quality Care Products LLC]

PROVIGIL (modafinil) Tablets [C-IV]

Provigil [Rebel Distributors Corp]

PROVIGIL (modafinil) Tablets [C-IV]

Provigil [Physicians Total Care, Inc.]

PROVIGIL (modafinil) Tablets [C-IV]

Lyophilized pegaspargase [Baxalta US Inc.]

LYOPHILIZED PEGASPARGASE

Granisetron hydrochloride [Ascend Laboratories, LLC]

Granisetron hydrochloride tablets

Olopatadine hydrochloride [Apotex Corp.]

Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1%



Advertisement
Quick Search
Advertisement
Advertisement